179 related articles for article (PubMed ID: 11431716)
1. Atypical endometrial hyperplasia shares genomic abnormalities with endometrioid carcinoma by comparative genomic hybridization.
Baloglu H; Cannizzaro LA; Jones J; Koss LG
Hum Pathol; 2001 Jun; 32(6):615-22. PubMed ID: 11431716
[TBL] [Abstract][Full Text] [Related]
2. Genetic imbalances in endometrial hyperplasia and endometrioid carcinoma detected by comparative genomic hybridization.
Muslumanoglu HM; Oner U; Ozalp S; Acikalin MF; Yalcin OT; Ozdemir M; Artan S
Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):107-14. PubMed ID: 15866096
[TBL] [Abstract][Full Text] [Related]
3. Detection of chromosomal anomalies in endometrial atypical hyperplasia and carcinoma by using fluorescence in situ hybridization.
Qian J; Weber D; Cochran R; Hossain D; Bostwick DG
Cancer Cytopathol; 2010 Apr; 118(2):97-104. PubMed ID: 20225199
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
5. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
[TBL] [Abstract][Full Text] [Related]
6. Genetic imbalances in precursor lesions of endometrial cancer detected by comparative genomic hybridization.
Kiechle M; Hinrichs M; Jacobsen A; Lüttges J; Pfisterer J; Kommoss F; Arnold N
Am J Pathol; 2000 Jun; 156(6):1827-33. PubMed ID: 10854205
[TBL] [Abstract][Full Text] [Related]
7. Precursors of endometrial clear cell carcinoma.
Fadare O; Liang SX; Ulukus EC; Chambers SK; Zheng W
Am J Surg Pathol; 2006 Dec; 30(12):1519-30. PubMed ID: 17122507
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of LH/hCG receptors in endometrial hyperplasia and carcinoma in anovulatory women.
Konishi I; Koshiyama M; Mandai M; Kuroda H; Yamamoto S; Nanbu K; Komatsu T; Matsushita K; Rao CV; Mori T
Gynecol Oncol; 1997 May; 65(2):273-80. PubMed ID: 9159337
[TBL] [Abstract][Full Text] [Related]
9. Genetic changes in paired atypical and usual ductal hyperplasia of the breast by comparative genomic hybridization.
Gong G; DeVries S; Chew KL; Cha I; Ljung BM; Waldman FM
Clin Cancer Res; 2001 Aug; 7(8):2410-4. PubMed ID: 11489820
[TBL] [Abstract][Full Text] [Related]
10. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Wheeler DT; Bristow RE; Kurman RJ
Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
[TBL] [Abstract][Full Text] [Related]
11. Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridization.
Kuukasjärvi T; Tanner M; Pennanen S; Karhu R; Visakorpi T; Isola J
Genes Chromosomes Cancer; 1997 Feb; 18(2):94-101. PubMed ID: 9115969
[TBL] [Abstract][Full Text] [Related]
12. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
13. Overrepresentation of 8q in carcinosarcomas and endometrial adenocarcinomas.
Schulten HJ; Gunawan B; Enders C; Donhuijsen K; Emons G; Füzesi L
Am J Clin Pathol; 2004 Oct; 122(4):546-51. PubMed ID: 15487452
[TBL] [Abstract][Full Text] [Related]
14. Mutation of beta-catenin gene in endometrial cancer but not in associated hyperplasia.
Ashihara K; Saito T; Mizumoto H; Nishimura M; Tanaka R; Kudo R
Med Electron Microsc; 2002 Mar; 35(1):9-15. PubMed ID: 12111402
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1.
Briese J; Schulte HM; Bamberger CM; Löning T; Bamberger AM
Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE
Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060
[TBL] [Abstract][Full Text] [Related]
17. [Chromosomal aberration in vulvar squamous cell carcinoma analyzed by comparative genomic hybridization].
Ouyang L; Zhang SL; Chen RL; Li B; Chen LL
Ai Zheng; 2007 Jun; 26(6):572-5. PubMed ID: 17562259
[TBL] [Abstract][Full Text] [Related]
18. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
19. Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors.
Sturgeon SR; Sherman ME; Kurman RJ; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Brinton LA
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):231-5. PubMed ID: 9521439
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer.
Garuti G; Cellani F; Centinaio G; Sita G; Nalli G; Luerti M
Gynecol Oncol; 2006 May; 101(2):269-73. PubMed ID: 16297970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]